Inogen Inc (INGN): Alison Bauerlein , EVP, Finance & CFO of Inogen Inc sold 4,360 shares on Mar 31, 2016. The Insider selling transaction was disclosed on Apr 4, 2016 to the Securities and Exchange Commission. The shares were sold at $45.00 per share for a total value of $193,290.42.
Company has been under the radar of several Street Analysts.Inogen Inc is Initiated by Piper Jaffray to Neutral. The Rating was issued on Mar 24, 2016.Inogen Inc is Reiterated by Needham to Strong Buy while Lowering the Price Target of the company shares to $ 45 from a previous price target of $55 . The Rating was issued on Feb 12, 2016.
Currently the company Insiders own 5.31% of Inogen Inc shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by -7.12%.Institutional Investors own 97.97% of Inogen Inc shares.During last six month period, the net percent change held by insiders has seen a change of -14.83%.
Inogen Inc: On Wednesday, Mar 30, 2016 heightened volatility was witnessed in Inogen Inc which led to swings in the share price. The shares opened for trading at $42 and hit $42.34 on the upside , eventually ending the session at $42.01, with a gain of 0.38% or 0.16 points. The heightened volatility saw the trading volume jump to 1,80,321 shares. The 52-week high of the share price is $55.98 and the company has a market cap of $834 M . The 52-week low of the share price is at $28.814.
Inogen Inc. is a medical technology company. The Company is engaged in developing manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company offers Inogen One systems such as Inogen One G3 and G2 that concentrate the air around the patients to offer a single source of supplemental oxygen. The Inogen One G3 and G2 have up to 4.5 and five hours of battery life respectively. The Company’s Inogen One G2 is effective for nocturnal use.